Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

PreScription: Two Lessons in 17-Hydroxyprogesterone

Author(s):  Menighan Thomas E

Issue:  Jul/Aug 2011 - Volume 15, Number 4
View All Articles in Issue

Page(s):  268

PreScription: Two Lessons in 17-Hydroxyprogesterone Page 1

Download in electronic PDF format for $75

Abstract:  

Related Keywords: US Food and Drug Administration, FDA, Pharmacy Compounding Accreditation Board, PCAB, standards

Related Categories: ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Two Lessons in 17-Hydroxyprogesterone
Menighan Thomas E
Jul/Aug 2011
Pg. 268

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures
Cabaleiro Joe
Sep/Oct 2007
Pg. 397-398

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Why Become Pharmacy Compounding Accreditation Board Accredited?
Dillon L Rad
Nov/Dec 2016
Pg. 469-474

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
Jan/Feb 2012
Pg. 86-87

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations
Cabaleiro Joe
Sep/Oct 2008
Pg. 432-433

PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future
Cabaleiro Joe
Nov/Dec 2014
Pg. 526-527

U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T
, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019
Pg. 32-33

PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
Mar/Apr 2008
Pg. 174-175

Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Kupiec Tom
, Kemp Jesse
Jul/Aug 2007
Pg. 326-327

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview
Cabaleiro Joe
Jul/Aug 2007
Pg. 297-298

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
Jul/Aug 2020
Pg. 296-297

Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH
, Mixon William, Allan W Chris
Sep/Oct 2020
Pg. 371-379

PreScription: Cabaleiro Brings Solid Record to the Pharmacy Compounding Accreditation Board
Menighan Thomas E
Mar/Apr 2011
Pg. 92

Return to Top